logo-loader
viewIXICO PLC

Full interview: IXICO PLC lands two new clients as it continues to expand portfolio

IXICO PLC's (LON:IXI) Alison Howie tells Proactive London's Andrew Scott they've secured two new client contracts with a combined value of over £1mln.

She adds there's also been a significant change order that expands its involvement in a phase III clinical trial for Huntington's disease worth an additional £900,000.

Quick facts: IXICO PLC

Price: 71.4745 GBX

AIM:IXI
Market: AIM
Market Cap: £33.52 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of IXICO PLC named herein, including the promotion by the Company of IXICO PLC in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Proactive meets IXICO's new chief business officer Lammert...

Lammert Albers sits down with Proactive London's Andrew Scott soon after his appointment as IXICO PLC’s (LON:IXI) chief business officer. With expertise of the Alzheimer's disease trials market he says he'll be responsible for executing the company's global business development strategy in...

1 week, 6 days ago

2 min read